Boryung Biopharma to enter basic vaccine business.

Published: 2005-05-30 06:58:00

Updated: 2005-05-30 06:58:00

Boryung Biopharma made an exclusive distribution agreement with SIIL (Serum Institute of India Ltd), a leading Indian drug company, initially distributing 2 vaccines of SIIL, measle/rubeola and diphtheria/tetanus, which were recognized by WHO and predominated in the world markets.

Boryung Biopharma plans to sell MMR in bulk and finished form and gradually to extend more products in the futur...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.